Debt to Capital Ratio: A measurement of a company's financial leverage, calculated as the company's long-term debt divided by its total capital. Calculated as: Total Long-Term Debt / (Total Long-Term Debt + Shareholders Equity)
Bright Minds Biosciences Inc. (DRUG) had Debt to Capital Ratio of 0.00 for the most recently reported fiscal quarter, ending 2024-12-31.
| Income Statement Financials | |
-- |
|
$0.04M |
|
-- |
|
-- |
|
$1.16M |
|
$-1.16M |
|
$1.20M |
|
$0.04M |
|
$0.04M |
|
$0.04M |
|
$0.04M |
|
$0.04M |
|
$0.04M |
|
$-1.16M |
|
$-1.14M |
|
6.17M |
|
6.64M |
|
$0.01 |
|
$0.01 |
|
| Balance Sheet Financials | |
$41.58M |
|
-- |
|
$0.13M |
|
$41.71M |
|
$0.33M |
|
$0.08M |
|
$0.08M |
|
$0.41M |
|
$41.30M |
|
$41.30M |
|
$41.30M |
|
6.99M |
|
| Cash Flow Statement Financials | |
$-1.07M |
|
-- |
|
$37.17M |
|
$4.09M |
|
$41.35M |
|
$37.26M |
|
$0.13M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
126.15 |
|
-- |
|
-- |
|
|
Debt to Capital Ratio |
0.00 |
0.00 |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
$-1.07M |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
0.09% |
|
0.09% |
|
0.09% |
|
0.09% |
|
$5.91 |
|
$-0.16 |
|
$-0.16 |
|